Press release
Bioanalytical Testing Services Market Worth USD 3.7 Billion by 2025 | Leading Companies are Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), and IQVIA Inc (US)
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12254971&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr
The growth in this market is driven by factors such as the increasing preference for outsourcing analytical testing, rising focus on the analytical testing of biologics and biosimilars, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals and the pricing pressure faced by major players are the major factors that are expected to restrain the growth of this market during the forecast period.
The oncology applications segment accounted for the largest share of the market, by application, in 2019
Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other application areas. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.
Browse in-depth TOC on "Bioanalytical Testing Services Market"
135 - Tables
49 - Figures
203 - Pages
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=12254971&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr
The cell-based assays segment accounted for the largest market share in 2019
Based on the type of service, the bioanalytical testing services market is segmented into cell-based assays; virology testing; method development optimization and validation; serology, immunogenicity, and neutralizing antibodies; biomarker testing; pharmacokinetic testing; and other services (biologics characterization, extractable & leachable testing, and stability testing). The cell-based assays segment accounted for the largest share of the bioanalytical testing services market in 2019. The large share of this segment can be attributed to the high and growing utilization of cell-based assays in developing newer drugs as a result of the increasing prevalence of chronic diseases.
North America was the largest regional market for bioanalytical testing services in 2019
The global bioanalytical testing services market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth in the North American market can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries and the rising prevalence of chronic and infectious diseases.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=12254971&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr
Key Players
The prominent players operating in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK).
Contact Us
Mr. Aashish Mehra
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's(TM) flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioanalytical Testing Services Market Worth USD 3.7 Billion by 2025 | Leading Companies are Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), and IQVIA Inc (US) here
News-ID: 2046020 • Views: …
More Releases from MarketsandMarkets
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | Marketsand …
Monoclonal Antibody (mABs) Therapeutics Market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The monoclonal antibody therapeutics market is primarily driven by factors such as increasing prevalence of chronic diseases like cancer, autoimmune disorders, and infectious diseases. Technological advancements…
Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
Optometry Equipment Market in terms of revenue was estimated to be worth $4.5 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029 according to a new report by MarketsandMarkets™. The principal drivers propelling the expansion of this market are the growing prevalence of eye illnesses, advancements in ophthalmic device technology, expanding government initiatives aimed at preventing visual…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
More Releases for Testing
Test Automation Market | latest automation testing tools, automation testing too …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Test Automation Market “
The “Test Automation Market” report provides analysis of the global test automation market for the period 2015–2025, wherein the years from 2017 to 2025 is the forecast period and 2016 is considered as the base year. The report precisely…
Sexually Transmitted Disease (STD) Diagnosis Market Report 2018: Segmentation by …
Global Sexually Transmitted Disease (STD) Diagnosis market research report provides company profile for Biocartis, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Molecular Diagnostics Market Application On Infectious Disease Testing, Cardiova …
Worldwide Market Reports recently released “Global Molecular Diagnostics Market Research Report 2017” that centers around the latest developing trends and technologies in the Molecular Diagnostics Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022.
During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives and other…
Test Automation Market Quadruples by 2023; with a ~ 15.34 % of Whooping CAGR | C …
New Market Research Reports Title "Test Automation Market 2018" Has Been Added to Crystal Market Research Report database.
Test Automation Market - Competitive Insights:
The leading players in the market are Cognizant Corporation, IBM, Hewlett-Packard, Capgemini, Tata Consultancy Services and Infosys. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Test…
Latest Trend On Testing as a Service (TaaS) Market Research Report, Status and P …
The various factors supporting the market’s trajectory and those posing threat are studied in the report in detail. Furthermore, the market study segments the Global TaaS Industry 2018 Market Sales Market based on application and industry chain structure. In these sections, it covers various factors influencing the market’s trajectory across the segments. Furthermore, it identifies the most profitable of them all to help investors take the well-versed decision. The…
Food Safety Testing Market Fostering Industry On Safety Test, Pathogen Testing , …
Global food safety testing market is expected to reach USD 22,327.02 million by 2025 from USD 12,760.00 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample of This Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-food-safety-testing-market
Global Industry Segmentation:
The major factors contributing to the growth…
